Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment

Breast cancer is the second most common cancer in women worldwide. Long-term treatment with conventional chemotherapy may result in severe systemic side effects. Therefore, the localized delivery of chemotherapy helps to overcome such a problem. In this article, self-assembling hydrogels were constr...

Full description

Bibliographic Details
Main Authors: Saud Almawash, Ahmed M. Mohammed, Mohamed A. El Hamd, Shaaban K. Osman
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/9/4/326
_version_ 1797605387111759872
author Saud Almawash
Ahmed M. Mohammed
Mohamed A. El Hamd
Shaaban K. Osman
author_facet Saud Almawash
Ahmed M. Mohammed
Mohamed A. El Hamd
Shaaban K. Osman
author_sort Saud Almawash
collection DOAJ
description Breast cancer is the second most common cancer in women worldwide. Long-term treatment with conventional chemotherapy may result in severe systemic side effects. Therefore, the localized delivery of chemotherapy helps to overcome such a problem. In this article, self-assembling hydrogels were constructed via inclusion complexation between host β-cyclodextrin polymers (8armPEG20k-CD and pβ-CD) and the guest polymers 8-armed poly(ethylene glycol) capped either with cholesterol (8armPEG20k-chol) or adamantane (8armPEG20k-Ad) and were loaded with 5-fluorouracil (5-FU) and methotrexate (MTX). The prepared hydrogels were characterized by SEM and rheological behaviors. The in vitro release of 5-FU and MTX was studied. The cytotoxicity of our modified systems was investigated against breast tumor cells (MCF-7) using an MTT assay. Additionally, the histopathological changes in breast tissues were monitored before and after their intratumor injection. The results of rheological characterization indicated the viscoelastic behavior in all cases except for 8armPEG-Ad. In vitro release results showed a variable range of release profiles from 6 to 21 days, depending on the hydrogel composition. MTT findings indicated the inhibition ability of our systems against the viability of cancer cells depending on the kind and concentration of the hydrogel and the incubation period. Moreover, the results of histopathology showed the improvement of cancer manifestation (swelling and inflammation) after intratumor injection of loaded hydrogel systems. In conclusion, the obtained results indicated the applicability of the modified hydrogels as injectable vehicles for both loading and controlled release of anticancer therapies.
first_indexed 2024-03-11T05:00:22Z
format Article
id doaj.art-addbc196bc6e4008a450233f910206bd
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-11T05:00:22Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-addbc196bc6e4008a450233f910206bd2023-11-17T19:21:52ZengMDPI AGGels2310-28612023-04-019432610.3390/gels9040326Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer TreatmentSaud Almawash0Ahmed M. Mohammed1Mohamed A. El Hamd2Shaaban K. Osman3Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqraa 11961, Saudi ArabiaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, EgyptDepartment of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqraa 11961, Saudi ArabiaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, EgyptBreast cancer is the second most common cancer in women worldwide. Long-term treatment with conventional chemotherapy may result in severe systemic side effects. Therefore, the localized delivery of chemotherapy helps to overcome such a problem. In this article, self-assembling hydrogels were constructed via inclusion complexation between host β-cyclodextrin polymers (8armPEG20k-CD and pβ-CD) and the guest polymers 8-armed poly(ethylene glycol) capped either with cholesterol (8armPEG20k-chol) or adamantane (8armPEG20k-Ad) and were loaded with 5-fluorouracil (5-FU) and methotrexate (MTX). The prepared hydrogels were characterized by SEM and rheological behaviors. The in vitro release of 5-FU and MTX was studied. The cytotoxicity of our modified systems was investigated against breast tumor cells (MCF-7) using an MTT assay. Additionally, the histopathological changes in breast tissues were monitored before and after their intratumor injection. The results of rheological characterization indicated the viscoelastic behavior in all cases except for 8armPEG-Ad. In vitro release results showed a variable range of release profiles from 6 to 21 days, depending on the hydrogel composition. MTT findings indicated the inhibition ability of our systems against the viability of cancer cells depending on the kind and concentration of the hydrogel and the incubation period. Moreover, the results of histopathology showed the improvement of cancer manifestation (swelling and inflammation) after intratumor injection of loaded hydrogel systems. In conclusion, the obtained results indicated the applicability of the modified hydrogels as injectable vehicles for both loading and controlled release of anticancer therapies.https://www.mdpi.com/2310-2861/9/4/326β-cyclodextrin polymers5-fluorouracilmethotrexatecholesterolpolyethylene glycolinjectable hydrogels
spellingShingle Saud Almawash
Ahmed M. Mohammed
Mohamed A. El Hamd
Shaaban K. Osman
Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
Gels
β-cyclodextrin polymers
5-fluorouracil
methotrexate
cholesterol
polyethylene glycol
injectable hydrogels
title Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
title_full Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
title_fullStr Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
title_full_unstemmed Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
title_short Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment
title_sort injectable hydrogels based on cyclodextrin cholesterol inclusion complexation and loaded with 5 fluorouracil methotrexate for breast cancer treatment
topic β-cyclodextrin polymers
5-fluorouracil
methotrexate
cholesterol
polyethylene glycol
injectable hydrogels
url https://www.mdpi.com/2310-2861/9/4/326
work_keys_str_mv AT saudalmawash injectablehydrogelsbasedoncyclodextrincholesterolinclusioncomplexationandloadedwith5fluorouracilmethotrexateforbreastcancertreatment
AT ahmedmmohammed injectablehydrogelsbasedoncyclodextrincholesterolinclusioncomplexationandloadedwith5fluorouracilmethotrexateforbreastcancertreatment
AT mohamedaelhamd injectablehydrogelsbasedoncyclodextrincholesterolinclusioncomplexationandloadedwith5fluorouracilmethotrexateforbreastcancertreatment
AT shaabankosman injectablehydrogelsbasedoncyclodextrincholesterolinclusioncomplexationandloadedwith5fluorouracilmethotrexateforbreastcancertreatment